Preparation and characterization of rivastigmine loaded chitosan nanoparticles

Journal of Pharmaceutical Sciences and Research

Volumn 3, Issue 5, 2011, Pages 1227-1232

  Kaur, Simar Preet ^a   Rao, Rekha ^a   Hussain, Afzal ^b   Khatkar, Sarita ^c  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

^b GURU NANAK DEV UNIVERSITY   (India)

^c Vaish Institute of Pharmaceutical Education and Research   (India)

Author keywords

Chitosan; Ionic gelation; Nanoparticles; Nanotechnology; Rivastigmine; Sustained release

Indexed keywords

CHITOSAN; DRUG CARRIER; NANOPARTICLE; RIVASTIGMINE; TRIPOLYPHOSPHATE;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; DRUG FORMULATION; DRUG STRUCTURE; GELATION; IN VITRO STUDY; NANOPHARMACEUTICS; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; TARGET ORGAN; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 79959683373     PISSN: None     EISSN: 09751459     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chakraborty, C., Sarkar, B., Hsu, C. H., Wen, Z.H., Lin, C. S., Shieh, P. C., J. Neurooncol. 2009, 93, 285-286.
2. Chen, Y., Dalwadi, G., Benson, H. A. E., Curr.Drug Deliv. 1994, 1(4), 361-376.
3. Lockman, P. R., Mumper, R. J., Khan, M. A., Allen, D. D., Drug Dev. Ind. Pharm. 2002, 28(1), 1-13.
4. Saha, P., Goyal, A. K., Rath, G., Trop. J. Pharm.Res. 2010, 9 (5), 483-488.
5. Modi, G., Pillay, V., Choonara, Y. E., Ndesendo, V. M. K., Toit, L. C., Naidoo, D., Prog. inNeurobiol. 2009, 88, 272-285.
6. Dustgani, A., Farahani, E. V., Imani, M., Iran. J.Pharm. Sci. 2008, 4(2), 111-114.
7. Hughes, G. A., Nanomedicine: Nanotechnology,Biology, and Medicine. 2005, 1, 22-30.
8. Craparo, E. F., Pitarresi, G., Bondi, M. L., Casaletto, M. P., Licciardi, M., Giammona, G., Macromolecular Biosciences. 2008, 8, 247-259.
9. Singh, R., Lillard, J. W., Experimental andMolecular Pathology. 2009, 86, 215-223.
10. Lockman, P. R., Mumper, R. J., Koziara, J. M., Allen, D. D., J. Drug Target. 2004, 12(9-10.), 635-641.
11. Kreuter, J., Adv. Drug Deliv. Rev. 2001, 47(1), 65-81.
12. Ringe, K., Walz, C. M., Sabe, B. A., Encyclopediaof Nanoscience and Nanotechnology. 2004, 7, 91-104.
13. Malhotra, M., Kulamarva, A., Sebak, S., Paul, A., Bhathena, J., Mirzaei, M., Prakash, S., Drug Dev.Ind. Pharm. 2009, 35(6), 719-726.
14. Tekin, S., Lane, R., Progress in Neurotherapeuticsand Neuropsychopharmacology. 2006, 1(1), 13-25.
15. Birks, J., Evans, J. G., Iakovidou, V., Tsolaki, M., Holt, F. E., Cochrane Database Syst Rev. 2009, 2, 1-168.
16. Lefèvre, G., Pommier, F., Sedek, G., Allison, M.,Huang, H. L. A., Beate K., Ho, Y. Y., Silke, A. D., J. Clin. Pharmacol. 2008, 48(2), 246-252.
17. Williams, B. R., Nazarians, A., Gill, M. A.,Clinical Therapeutics. 2003, 25, 1634-1653.
18. Urrusuno, R. F., Calvo, P., Lopez, C. R., Jato, J. L.V., Alonso, M. J., Pharm. Res. 1999, 16(10), 1576-1581.
19. Chenguang, L., Yulong, T., Chengsheng, L., Xiguang, C., Lejun, Y., J. Ocean Univ. of China(Oceanic and Coastal Sea Research). 2007, 6(3), 237-243.
20. Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., Alonso, M. J., J. Control. Rel. 2001, 73, 255-267.
21. Li, F., Li, J., Wen, X., Zhou, S., Tong, X., Su, P., Li, H., Shi, D., Mater. Sci. Engi:C. 2010, 29(8), 2392-2397.
22. Abdelwahed, W., Degobert, G., Stainmesse, S., Fessi, H., Adv. Drug Del. Reviews. 2006, 58, 1688-1713.
23. Bhumkar, D. R., Pokharkar, V. B., AAPS Pharm.Sci. Tech. 2006, 7(2), E 1-6.
24. Boonsongrit, Y., Mitrevej, A., Mueller, B. W., Europ. J. Pharm. Biopharm. 2006, 62, 267-274.
25. Sivabalan, M., Shering, A., Jose, A., Nivila, G., Pharmaci Globale (IJCP). 2011, 2(1), 1-4.